Blue Origin Flies Thrill Seekers to Space, Including Oldest Astronaut

Jeff Bezos-backed Blue Origin resumes its flights to the edge of space, carrying six people seated in a capsule atop the New Shepard rocket, ending a near two-year pause of crewed operations following a 2022 mission failure in Van Horn, Texas, US May 19, 2024 in a still image from video.  Blue Origin/Handout via REUTERS
Jeff Bezos-backed Blue Origin resumes its flights to the edge of space, carrying six people seated in a capsule atop the New Shepard rocket, ending a near two-year pause of crewed operations following a 2022 mission failure in Van Horn, Texas, US May 19, 2024 in a still image from video. Blue Origin/Handout via REUTERS
TT

Blue Origin Flies Thrill Seekers to Space, Including Oldest Astronaut

Jeff Bezos-backed Blue Origin resumes its flights to the edge of space, carrying six people seated in a capsule atop the New Shepard rocket, ending a near two-year pause of crewed operations following a 2022 mission failure in Van Horn, Texas, US May 19, 2024 in a still image from video.  Blue Origin/Handout via REUTERS
Jeff Bezos-backed Blue Origin resumes its flights to the edge of space, carrying six people seated in a capsule atop the New Shepard rocket, ending a near two-year pause of crewed operations following a 2022 mission failure in Van Horn, Texas, US May 19, 2024 in a still image from video. Blue Origin/Handout via REUTERS

After a nearly two-year hiatus, Blue Origin flew adventurers to space on Sunday, including a former Air Force pilot who was denied the chance to be the United States' first Black astronaut decades ago, Agence France Presse reported.

It was the first crewed launch for the enterprise owned and founded by Amazon billionaire Jeff Bezos since a rocket mishap in 2022 left rival Virgin Galactic as the sole operator in the fledgling suborbital tourism market.

Six people including the sculptor Ed Dwight, who was on track to become NASA's first astronaut of color in the 1960s before being controversially spurned, launched around 09:36 am local time (1436 GMT) from the Launch Site One base in west Texas, a live feed showed.

Dwight -- at 90 years, 8 months and 10 days -- became the oldest person to ever go to space.

"This is a life-changing experience, everybody needs to do this," he exclaimed after the flight.

"I thought I didn't really need this in my life," he added, reflecting on his omission from the astronaut corps, which was his first experience with failure as a young man.

"But I lied," he added, with a hearty laugh.

"You take everything you imagined, you multiply it roughly by 100 and you are still quite far from reality," crewmate and French entrepreneur Sylvain Chiron told AFP.

"I'm not quite back down to Earth yet."

Mission NS-25 is the seventh human flight for Blue Origin, which sees short jaunts on the New Shepard suborbital vehicle as a stepping stone to greater ambitions, including the development of a full-fledged heavy rocket and lunar lander.

Including Sunday's crew, the company has flown 37 people aboard New Shepard -- a small, fully reusable rocket system named after Alan Shepard, the first American in space.

The program encountered a setback when a New Shepard rocket caught fire shortly after launch on September 12, 2022, even though the uncrewed capsule ejected safely.

A federal investigation revealed an overheating engine nozzle was at fault. Blue Origin took corrective steps and carried out a successful uncrewed launch in December 2023, paving the way for Sunday's mission.

After liftoff, the sleek and roomy capsule separated from the booster, which produces zero carbon emissions. The rocket performed a precision vertical landing.

As the spaceship soared beyond the Karman Line, the internationally recognized boundary of space 62 miles (100 kilometers) above sea level, passengers had the chance to marvel at the Earth's curvature and unbuckle their seatbelts to float -- or somersault -- during a few minutes of weightlessness.

The capsule then reentered the atmosphere, deploying its parachutes for a desert landing in a puff of sand. However, one of the three parachutes failed to fully inflate, possibly resulting in a harder landing than expected.

Asked for comment, a Blue Origin spokesperson stressed its system was designed with multiple fail-safes.

"The capsule is designed to safely land with one parachute. The overall mission was a success, and all of our astronauts are excited to be back," the spokesperson said.

In all, the mission lasted around 11 minutes roundtrip.

Bezos himself was on the program's first crewed flight in 2021. A few months later, Star Trek's William Shatner blurred the lines between science fiction and reality when he became the world's oldest astronaut at age 90, decades after he first played a space traveler.

Dwight, who was almost two months older than Shatner at the time of his flight, became only the second nonagenarian to venture beyond Earth.

Astronaut John Glenn remains the oldest to orbit the planet, a feat he achieved in 1998 at the age of 77 aboard the Space Shuttle Discovery.

Sunday's mission finally gave Dwight the chance he was denied decades ago.

He was an elite test pilot when he was appointed by then-president John F Kennedy to join a highly competitive Air Force program known as a Pathway for the astronaut corps, but was ultimately not picked.

He left the military in 1966, citing the strain of racial politics, before dedicating his life to telling Black history through sculpture. His art, displayed around the country, includes iconic figures like Martin Luther King Jr, Frederick Douglass, Harriet Tubman, and more.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”